Abstract
Background: The transcriptional repressor BCL6 is an oncogenic driver often found to be deregulated in lymphoid malignancies. We report the optimisation of our previously reported benzimidazolone molecular glue type degrader CCT369260 to CCT373566, a highly potent probe suitable for sustained depletion of BCL6 in vivo.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
